Posts

Showing posts from February, 2023

Androgenetic Alopecia Treatment Market Forecast: Billions in Revenue Expected

Image
A hereditary disease called androgenetic alopecia is brought on by an overreaction to androgens. This disorder, which can affect up to 50% of both sexes, is characterized by the progressive loss of scalp-level terminal hair at any point after puberty. Androgenetic alopecia is the typical cause of hair loss in both men and women, according to Asadi (2020). As per the DelveInsight assessment, the total number of prevalent cases of androgenetic alopecia was more than 194 million in the 7MM in 2021. The highest number of cases was seen in EU4 and the UK. Assessments showed that it affected about 50 million men and 30 million women in the United States; it begins in early adolescence and progresses with age. Additionally, more than 50% of men over 50 experience hair loss, whereas, in women, hair loss is more likely to occur after menopause. Social Stigma Related to Androgenetic Alopecia Hair plays a significant role in one's self-perception in today's society; as a result, hair lo

Market Impact of Biologics on Nasal Polyposis Treatment

Image
  Nasal polyposis causes benign growths in the nasal mucosa that restrict the nasal airway and are a common ailment. They lower quality of life (QoL), the Nasal Polyps symptoms cause hyposmia or anosmia, and impair sleep in people who are affected. They are a prevalent subset of chronic rhinosinusitis that are frequently linked to persistent nasal inflammation and ailments including asthma (CRS). About 25% of those with chronic rhinosinusitis (CRS) who are also diagnosed with nasal polyps have a disease called chronic rhinosinusitis with nasal polyps (CRSwNP), which can be quite debilitating in adulthood. The Current Nasal Polyposis Treatment Landscape The main goals of modern nasal polyposis treatment are to reduce polyp growth, postpone surgery, or avoid relapse following surgery. Recurrence rates are both high and common. Nasal corticosteroids are typically the first line of treatment for nasal irritation because the cause is typically unclear. Injectable corticosteroids may be us